Your Journey To Health
GlobeStar Therapeutics Corporation (OTCBB: GSTC) is a pioneer in the field of Multiple Sclerosis and other diseases. Our transformative therapies for the management of chronic neurodegenerative diseases are life-changing. Our patented therapies introduce a formulation of previously approved drugs which have been shown in clinical trials to improve the quality of life for these patients.
Are you a GlobeStar investor or interested in becoming one? Learn more about us and the benefits that come from joining our team.
GlobeStar Therapeutics Corporation (OTCBB: GSTC) is an American biotechnology company originally organized in 2011, headquartered in Houston, Texas with offices in the State of Washington, focused on developing innovative therapies for people with serious and life-threating rare disorders.
The Company patented and sold for $10 million of preferred shares a treatment for peripheral artery disease (PAD) called LiprostinTM followed by acquiring an exclusive license for a patented method of treating neurodegenerative diseases such as Multiple Sclerosis by administering a synergistically effective amount of the composition to an individual suffering from neurodegeneration and treating neurodegeneration.
We are in discussions with several contract research organizations to assist with our submission of new drug application for global marketing.
Years of Experience
In The News
As a publicly traded company, GlobeStar provides news on its operations through press release distributors like business wire, but it provides the same news here in an expanded format with links to all of the initial released locations and expanded images. this conforms to regulation FD disclosure requirements.
When people begin to develop a symptom they’ve never experienced before, including: vision loss, dizziness, mood swings, severe back pain, numbness and more, we begin to wonder what our bodies are dealing with. It is stressful. It is upsetting and it produces a lot...
FINRA Approval for the AngioSoma name change is effective immediately. RICHLAND, WA / ACCESSWIRE / July 6, 2021 / AngioSoma, Inc. (OTC PINK:SOAN) is now officially GlobeStar Therapeutics Corporation (OTC PINK:GSTC). This announcement is effective immediately and the...
Angiosoma, Inc., Soon to Be Globestar Therapeutics Corporation, Welcomes Kaushik Srinivasan, CEO, Radiant Health to the Medical Advisory Board
Srinivasan's medical management experience, leadership positions, and advisory experience will add additional depth to the AngioSoma team. RICHLAND, WA / ACCESSWIRE / July 1, 2021 / AngioSoma, Inc. (OTC PINK:SOAN) has added Kaushik Srinivasan, CEO, Radiant Health, to...